Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2000

View Archived Issues

Novartis and Geneva Proteomics establish proteomics alliance

Idec Pharmaceuticals outlines significant Q3 events

IntraDose shows promise in treating liver metastases from colorectal cancer

Maxamine inhibits sarcomas in preclinical study

NIH awards Siga grant for vaccine research

AstraZeneca licenses antiarrhythmic drug candidate from Nortran

Phase III trial reveals potency of H. pylori treatment

IBS treatment launched in Japan by Hokuriku and Fujisawa

Meningococcal C meningitis vaccine approved for very young infants

Status of Dendreon's dendritic cell-based vaccines updated

Antidepressant-like activity observed in validated animal model for NK1 receptor antagonist

AF-2785 and related compounds as potential new male antifertility agents

Nonpeptide Y1 antagonist H-409/22 examined for in vivo effects on vascular responses

NCX-4016 superior to aspirin in reducing myocardial infarct size in animal model

New gelatinase inhibitors suppress endothelial cell proliferation and invasion

First topical treatment for AIDS-related Kaposi's sarcoma approved in E.U.

Cellular experiments suggest potential role for new dimer in prostate cancer therapy

Lorus reports promising phase I/II results with anticancer drug; supply alliance formed

NicOx designs improved antiinflammatory, analgesic and antithrombotic compounds

Preparation, activity and use of new acetylcholinesterase inhibitors reported by Eisai

AHP's new estrogen receptor modulators are useful in bone and cardiovascular diseases

Novel compounds identified at Merck as factor Xa inhibitors

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Elan receives patent coverage for new integrin receptor antagonists

Potent new anti-HIV agents designed at Korean research institute

Ketolides from Abbott endowed with potent antibacterial activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...